Fund Name | Location |
Agrinnovation | Israel, Jerusalem, Jerusalem District |
Bull City Venture Partners | North Carolina, Raleigh, United States |
Chicago Growth Partners | Chicago, Illinois, United States |
Coventry Capital | Delaware, United States, Wilmington |
CVCapital | China, Shanghai |
DiamondStream Partners | Seattle, United States, Washington |
DonBest | California, Los Angeles, United States |
Excelsa Ventures | England, London, United Kingdom |
Giant Rich Co., Ltd. | England, London, United Kingdom |
KDC Media Fund | Israel, Tel Aviv, Tel Aviv District |
Keddoo | Beijing, China, Haidian |
Mahindra finance | India, Maharashtra, Mumbai |
Necotium | Barcelona, Catalonia, Spain |
Odyssey 44 | Czechia, Prague, Prague |
reinmkr capital | California, Marina Del Rey, United States |
TriTech Software Systems | California, San Diego, United States |
Westfield Corporation | Australia, New South Wales, Sydney |
YuanMing Capital | Beijing, China, Haidian |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ENSEM Therapeutics | $10M | 23 Oct 2023 | Medford, Massachusetts, United States | ||
Taichu Biotechnology | 08 May 2023 | Shanghai, Shanghai, China | |||
LANMOU MEDIA | $463K | 08 Nov 2016 | Shanghai, China | ||
$3M | 26 May 2016 | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ENSEM Therapeutics | $10M | 23 Oct 2023 | Medford, Massachusetts, United States | ||
Taichu Biotechnology | 08 May 2023 | Shanghai, Shanghai, China | |||
LANMOU MEDIA | $463K | 08 Nov 2016 | Shanghai, China | ||
$3M | 26 May 2016 | China, Shanghai |